(Q77124843)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9712406%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

review article

1 reference

title

Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9712406%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9712406%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

A M Brodie

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9712406%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9712406%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Steroid Biochemistry and Molecular Biology

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9712406%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9712406%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9712406%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

1-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9712406%20AND%20SRC:MED&resulttype=core&format=json

Cancer in the European community and its member states

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Cancer statistics, 1993

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Breast cancer trends. Incidence, mortality, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

The increasing incidence of breast cancer since 1982: relevance of early detection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Systemic therapy in breast cancer: efficacy and cost utility

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

The Effect of an Aromatase Inhibitor, 4-Hydroxy-4-Androstene- 3,17-Dione, On Estrogen-Dependent Processes in Reproduction and Breast Cancer11

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Distribution and regulation of aromatase activity in the rat hypothalamus and limbic system.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Aromatization of androgens by muscle and adipose tissue in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Aromatase in the human testis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Intratesticular site of aromatase activity and possible function of testicular estradiol.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Immunocytochemical studies of aromatase in early and full-term human placental tissues: comparison with biochemical assays

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Expression of aromatase cytochrome P-450 in premenopausal and postmenopausal human ovaries: an immunocytochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Plasma Precursors of Estrogen. II. Correlation of the Extent of Conversion of Plasma Androstenedione to Estrone with Age1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Concentration of endogenous oestradiol as related to oestradiol receptor sites in breast tumor cytosol

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Aromatase activity in the breast and other peripheral tissues and its therapeutic regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Detection of aromatase and keratinocyte growth factor expression in breast tumors using reverse transcription-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Relationship between tumour aromatase activity, tumour characteristics and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Tissue-specific promoters regulate aromatase cytochrome P450 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Hormonal Regulation of the Differentiation of Cultured Ovarian Granulosa Cells*

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Estrogen formation in stromal cells of adipose tissue of women: induction by glucocorticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Regulation of Aromatase Activity of Stromal Cells Derived from Human Adipose Tissue*

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Mechanism and inhibition of cytochrome P-450 aromatase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Mechanistic studies on aromatase and related C-C bond cleaving P-450 enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Isolation of a full-length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in nonsteroidogenic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Studies on the mechanism of estrogen biosynthesis. 8. The development of inhibitors of the enzyme system in human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Biochemical and molecular aspects of aromatase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Suicide enzyme inhibitors as potential drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Hormonal therapy in cancer of the breast 16. The effect of Delta 1-testololactone on clinical course and hormonal excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone*

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

A dose response evaluation of delta-1-testololactone in advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Second generation aromatase inhibitor--4-hydroxyandrostenedione

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

4-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Arimidex: a potent and selective fourth-generation aromatase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

ARIMIDEX: a new oral, once-a-day aromatase inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2898%2900022-3

7 January 2021

10.1016/S0960-0760(98)00022-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9712406%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference